Nasal products – EMA [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2015-04-03 00:09 (4102 d 04:25 ago) – Posting: # 14659
Views: 3,668

Hi Lechia,

❝ Anyone with experience showing BE for nasal sprays for EMA?


Yes :-D

❝ Are all 3 of:


❝   – in vitro analyses

❝   – PK

❝   – therapeutic equivalence


❝ required for a generic product to be accepted on the market?


Generally, no, not at all. It may be much easier than that.

❝ There is a guidance discussing all in vitro assays required for EMA, but nothing on what in vivo studies must (also) be performed. I would appreciate any guidance, especially if based on experience.


You may indee be able to pull it off with in vitro data. If that doesn't work, you may resort to PK or PD. There is no unified view on it across EU countries, so pick your RMS well. And do not pick according to your most imæportant market or where your EU Headquarters is...

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
114 visitors (0 registered, 114 guests [including 12 identified bots]).
Forum time: 04:34 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5